1. Home
  2. SEPN vs REAX Comparison

SEPN vs REAX Comparison

Compare SEPN & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • REAX
  • Stock Information
  • Founded
  • SEPN 2022
  • REAX 2018
  • Country
  • SEPN United States
  • REAX United States
  • Employees
  • SEPN N/A
  • REAX N/A
  • Industry
  • SEPN
  • REAX
  • Sector
  • SEPN
  • REAX
  • Exchange
  • SEPN NYSE
  • REAX Nasdaq
  • Market Cap
  • SEPN 453.2M
  • REAX 814.5M
  • IPO Year
  • SEPN 2024
  • REAX N/A
  • Fundamental
  • Price
  • SEPN $11.37
  • REAX $4.25
  • Analyst Decision
  • SEPN Strong Buy
  • REAX Strong Buy
  • Analyst Count
  • SEPN 5
  • REAX 3
  • Target Price
  • SEPN $26.75
  • REAX $6.33
  • AVG Volume (30 Days)
  • SEPN 548.9K
  • REAX 1.2M
  • Earning Date
  • SEPN 08-15-2025
  • REAX 08-06-2025
  • Dividend Yield
  • SEPN N/A
  • REAX N/A
  • EPS Growth
  • SEPN N/A
  • REAX N/A
  • EPS
  • SEPN N/A
  • REAX N/A
  • Revenue
  • SEPN $977,000.00
  • REAX $1,417,877,000.00
  • Revenue This Year
  • SEPN N/A
  • REAX $43.20
  • Revenue Next Year
  • SEPN $526.96
  • REAX $15.30
  • P/E Ratio
  • SEPN N/A
  • REAX N/A
  • Revenue Growth
  • SEPN 108.76
  • REAX 81.30
  • 52 Week Low
  • SEPN $4.17
  • REAX $3.80
  • 52 Week High
  • SEPN $28.99
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • REAX 52.23
  • Support Level
  • SEPN N/A
  • REAX $4.23
  • Resistance Level
  • SEPN N/A
  • REAX $4.62
  • Average True Range (ATR)
  • SEPN 0.00
  • REAX 0.17
  • MACD
  • SEPN 0.00
  • REAX 0.03
  • Stochastic Oscillator
  • SEPN 0.00
  • REAX 60.37

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: